TVS iQube offers multiple battery options, ranging from 94 km to 212 km, with practical features and consistent performance.

Santa Monica, CA, March 31, 2026 (GLOBE NEWSWIRE)-- As gas prices continue to strain household budgets, a new national survey from Veo finds that higher fuel costs are prompting more car drivers to ...

More than 1 in 5 home sellers reduced the asking price in nine metropolitan areas last month, a Realtor.com study found. Eight of those nine metropolitan areas are found in just three states: Arizona, ...

Sold through the Nexa retail network, one of the key factors behind the Maruti Suzuki Baleno's popularity is its design. Maruti Suzuki offers a wide range of genuine accessories that can enhance its ...

MOTOR experts have revealed their pick of 20 best electric cars on sale right now. The list includes everything from budget-friendly runarounds to luxury motors with prices starting as little as £165 ...

Pennsylvania is among the top 10 states for the highest gas prices in the nation. According to AAA, as of March 9, Pennsylvania has an average price of $3.589 for regular gasoline, which is the eighth ...

Weight loss drugmaker Novo Nordisk will cut the list prices of Ozempic and Wegovy by up to 50% beginning in 2027, the company announced on Tuesday. Wegovy currently carries a list price of $1,349 per ...

Novo Nordisk NOVO.B1.16%increase; green up pointing triangle plans to slash U.S. list prices for its popular weight-loss and diabetes drugs Wegovy and Ozempic by up to half starting next year. Under ...

Novo Nordisk on Tuesday announced plans to cut the list price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 50% in the U.S. next year. The Danish drugmaker indicated ...

Amid efforts on several fronts to improve the affordability of its GLP-1 medications for diabetes and obesity, Novo Nordisk is taking a new approach by aiming straight for semaglutide’s list price.

Novo Nordisk on Tuesday said it plans to slash the monthly list prices of its popular obesity and diabetes drugs in the U.S. by up to 50% starting in 2027. The move aims to make the treatments more ...